152 related articles for article (PubMed ID: 29570169)
1. Telomerase reverse transcriptase promoter mutations and solar elastosis in cutaneous melanoma.
Lade-Keller J; Yuusufi S; Riber-Hansen R; Steiniche T; Stougaard M
Melanoma Res; 2018 Oct; 28(5):398-409. PubMed ID: 29570169
[TBL] [Abstract][Full Text] [Related]
2. Solar elastosis and cutaneous melanoma: a site-specific analysis.
Kvaskoff M; Pandeya N; Green AC; Perry S; Baxter C; Davis MB; Mortimore R; Westacott L; Wood D; Triscott J; Williamson R; Whiteman DC
Int J Cancer; 2015 Jun; 136(12):2900-11. PubMed ID: 25403328
[TBL] [Abstract][Full Text] [Related]
3. TERT promoter mutations are associated with poor prognosis in cutaneous squamous cell carcinoma.
Campos MA; Macedo S; Fernandes M; Pestana A; Pardal J; Batista R; Vinagre J; Sanches A; Baptista A; Lopes JM; Soares P
J Am Acad Dermatol; 2019 Mar; 80(3):660-669.e6. PubMed ID: 30165166
[TBL] [Abstract][Full Text] [Related]
4. Coexistence of TERT promoter and BRAF mutations in cutaneous melanoma is associated with more clinicopathological features of aggressiveness.
Macerola E; Loggini B; Giannini R; Garavello G; Giordano M; Proietti A; Niccoli C; Basolo F; Fontanini G
Virchows Arch; 2015 Aug; 467(2):177-84. PubMed ID: 26055532
[TBL] [Abstract][Full Text] [Related]
5. TERT Promoter Mutational Status in the Management of Cutaneous Melanoma: Comparison with Sentinel Lymph Node Biopsy.
Martins F; Martins C; Fernandes MS; Andrade MI; Lopes JM; Soares P; Pópulo H
Dermatology; 2022; 238(3):507-516. PubMed ID: 34569488
[TBL] [Abstract][Full Text] [Related]
6. Telomerase reverse transcriptase promoter mutations in primary cutaneous melanoma.
Heidenreich B; Nagore E; Rachakonda PS; Garcia-Casado Z; Requena C; Traves V; Becker J; Soufir N; Hemminki K; Kumar R
Nat Commun; 2014 Feb; 5():3401. PubMed ID: 24569790
[TBL] [Abstract][Full Text] [Related]
7. Melanoma coexisting with solar elastosis: a potential pitfall in the differential diagnosis between nevus and melanoma.
Konopinski JC; Danialan R; Torres-Cabala CA; Tetzlaff MT; Nagarajan P; Curry JL; Ivan D; Prieto VG; Aung PP
Hum Pathol; 2019 Feb; 84():270-274. PubMed ID: 30359637
[TBL] [Abstract][Full Text] [Related]
8. A retrosepctive histological study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. 6. The relation of dermal solar elastosis to sex, age and survival of the patient and to localization, histological type and level of invasion of the tumour.
Larsen TE; Grude TH
Acta Pathol Microbiol Scand A; 1979 Sep; 87A(5):361-6. PubMed ID: 525350
[TBL] [Abstract][Full Text] [Related]
9. TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma.
Griewank KG; Murali R; Puig-Butille JA; Schilling B; Livingstone E; Potrony M; Carrera C; Schimming T; Möller I; Schwamborn M; Sucker A; Hillen U; Badenas C; Malvehy J; Zimmer L; Scherag A; Puig S; Schadendorf D
J Natl Cancer Inst; 2014 Sep; 106(9):. PubMed ID: 25217772
[TBL] [Abstract][Full Text] [Related]
10. Solar elastosis in cutaneous melanoma.
Vollmer RT
Am J Clin Pathol; 2007 Aug; 128(2):260-4. PubMed ID: 17638660
[TBL] [Abstract][Full Text] [Related]
11. BRAF mutations in cutaneous melanoma are independently associated with age, anatomic site of the primary tumor, and the degree of solar elastosis at the primary tumor site.
Bauer J; Büttner P; Murali R; Okamoto I; Kolaitis NA; Landi MT; Scolyer RA; Bastian BC
Pigment Cell Melanoma Res; 2011 Apr; 24(2):345-51. PubMed ID: 21324100
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic findings and BRAF mutation in cutaneous melanoma in young adults.
Estrozi B; Machado J; Rodriguez R; Bacchi CE
Appl Immunohistochem Mol Morphol; 2014 Jan; 22(1):57-64. PubMed ID: 24471189
[TBL] [Abstract][Full Text] [Related]
13. The role of TERT promoter mutations in differentiating recurrent nevi from recurrent melanomas: A retrospective, case-control study.
Walton KE; Garfield EM; Zhang B; Quan VL; Shi K; Mohan LS; Haugh AM; VandenBoom T; Yazdan P; Isales MC; Panah E; Gerami P
J Am Acad Dermatol; 2019 Mar; 80(3):685-693. PubMed ID: 30287318
[TBL] [Abstract][Full Text] [Related]
14. Clinical implications of TERT promoter mutation on IDH mutation and MGMT promoter methylation in diffuse gliomas.
Kim HS; Kwon MJ; Song JH; Kim ES; Kim HY; Min KW
Pathol Res Pract; 2018 Jun; 214(6):881-888. PubMed ID: 29650441
[TBL] [Abstract][Full Text] [Related]
15. Etiologic and other factors predicting nevus-associated cutaneous malignant melanoma.
Purdue MP; From L; Armstrong BK; Kricker A; Gallagher RP; McLaughlin JR; Klar NS; Marrett LD;
Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):2015-22. PubMed ID: 16103454
[TBL] [Abstract][Full Text] [Related]
16. Sun exposure and mortality from melanoma.
Berwick M; Armstrong BK; Ben-Porat L; Fine J; Kricker A; Eberle C; Barnhill R
J Natl Cancer Inst; 2005 Feb; 97(3):195-9. PubMed ID: 15687362
[TBL] [Abstract][Full Text] [Related]
17. TERT promoter mutations and rs2853669 polymorphism: prognostic impact and interactions with common alterations in glioblastomas.
Nencha U; Rahimian A; Giry M; Sechi A; Mokhtari K; Polivka M; Schmitt Y; Di Stefano AL; Alentorn A; Labussière M; Sanson M
J Neurooncol; 2016 Feb; 126(3):441-6. PubMed ID: 26608520
[TBL] [Abstract][Full Text] [Related]
18. The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism.
Batista R; Cruvinel-Carloni A; Vinagre J; Peixoto J; Catarino TA; Campanella NC; Menezes W; Becker AP; de Almeida GC; Matsushita MM; Clara C; Neder L; Viana-Pereira M; Honavar M; Castro L; Lopes JM; Carvalho B; Vaz RM; Máximo V; Soares P; Sobrinho-Simões M; Reis RM; Lima J
Int J Cancer; 2016 Jul; 139(2):414-23. PubMed ID: 26914704
[TBL] [Abstract][Full Text] [Related]
19. Sun exposure and host phenotype as predictors of cutaneous melanoma associated with neval remnants or dermal elastosis.
Lee EY; Williamson R; Watt P; Hughes MC; Green AC; Whiteman DC
Int J Cancer; 2006 Aug; 119(3):636-42. PubMed ID: 16572428
[TBL] [Abstract][Full Text] [Related]
20. Factors Related to Nevus-Associated Cutaneous Melanoma: A Case-Case Study.
Pandeya N; Kvaskoff M; Olsen CM; Green AC; Perry S; Baxter C; Davis MB; Mortimore R; Westacott L; Wood D; Triscott J; Williamson R; Whiteman DC
J Invest Dermatol; 2018 Aug; 138(8):1816-1824. PubMed ID: 29524457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
